Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salesforce, Inc. Director's Dealing 2024

Sep 24, 2024

29776_dirs_2024-09-23_0eda3a48-6640-4082-b069-dc2b2f553d63.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Salesforce, Inc. (CRM)
CIK: 0001108524
Period of Report: 2024-09-22

Reporting Person: Millham Brian (President and COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-22 Common Stock M 1635 Acquired 1635 Direct
2024-09-22 Common Stock M 1707 Acquired 3342 Direct
2024-09-23 Common Stock S 821 $264.7813 Disposed 2521 Direct
2024-09-23 Common Stock S 858 $264.7813 Disposed 1663 Direct
2024-09-23 Common Stock M 2038 $186.51 Acquired 3701 Direct
2024-09-23 Common Stock M 2018 $215.17 Acquired 5719 Direct
2024-09-23 Common Stock S 863 $265.3604 Disposed 4856 Direct
2024-09-23 Common Stock S 2996 $267.1749 Disposed 1860 Direct
2024-09-23 Common Stock S 197 $267.7503 Disposed 1663 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-22 Restricted Stock Units $0 M 1635 Disposed 2025-03-22 Common Stock (1635) Direct
2024-09-22 Restricted Stock Units $0 M 1707 Disposed 2026-03-22 Common Stock (1707) Direct
2024-09-23 Non-qualified Stock Option (Right to Buy) $186.51 M 2038 Disposed 2030-03-22 Common Stock (2038) Direct
2024-09-23 Non-qualified Stock Option (Right to Buy) $215.17 M 2018 Disposed 2028-03-22 Common Stock (2018) Direct

Footnotes

F1: Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through September 22, 2024.

F2: As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.

F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $264.9900 to $265.7200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F4: Weighted average price. These shares were sold in multiple transactions at prices ranging from $266.3700 to $267.2500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F5: Weighted average price. These shares were sold in multiple transactions at prices ranging from $267.7300 to $267.7700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F6: Restricted Stock Units convert to shares of common stock on a one-for-one basis.

F7: These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.

F8: These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter.

F9: Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

F10: Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.